| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/12/2007 | WO2005112922A3 Benzamide compounds |
| 04/12/2007 | WO2005075460A3 Pyrrolopyrimidine derivatives for treating proliferative diseases |
| 04/12/2007 | WO2005047465A3 Method and antisense compound for potentiating anti-cancer agents |
| 04/12/2007 | WO2005032492A3 Site and rate selective prodrug formulations of d609 with antioxidant and anticancer activity |
| 04/12/2007 | WO2005011594A3 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 04/12/2007 | US20070083046 Morpholine derivatives as norepinephrine reuptake inhibitors |
| 04/12/2007 | US20070083045 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
| 04/12/2007 | US20070083031 Method of manufacture of polyacrolein |
| 04/12/2007 | US20070083006 Method for preparation of site-specific protein conjugates |
| 04/12/2007 | US20070082958 Methods for treatment of renal failure |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082956 The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity. |
| 04/12/2007 | US20070082955 Novel target protein of anticancer agent and novel anticancer agent (spnal) corresponding thereto |
| 04/12/2007 | US20070082954 Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives |
| 04/12/2007 | US20070082953 Use of l-dopa, derivatives thereof and medicaments comprising said compounds for the prophylaxis of psychotic diseases |
| 04/12/2007 | US20070082952 Pharmaceutical compositions, methods of preparation thereof, and methods of treatment |
| 04/12/2007 | US20070082951 protamine-mimetic compounds; calixarenes substituted with amino acids bearing salifiable amino groups; In post-surgical protocols to prevent thromboembolism, clotting and thrombi; to prevent clotting in dialysis circuits; side effects reduction; minimize the risk of hemorrhage in dialysed patients |
| 04/12/2007 | US20070082950 Method for producing vitamin a acetate |
| 04/12/2007 | US20070082949 Agent for preventing and treating language disorders |
| 04/12/2007 | US20070082948 Compounds and methods for delivery of prostacyclin analogs |
| 04/12/2007 | US20070082947 Use of phthalide derivatives for the treatment and prevention of diabetes mellitus |
| 04/12/2007 | US20070082946 Methods of treating mental diseases, inflammation and pain |
| 04/12/2007 | US20070082945 Discodermolide compositions |
| 04/12/2007 | US20070082944 Antimicrobial compositions and methods of use |
| 04/12/2007 | US20070082943 Process for preparation of substantially pure glimepiride |
| 04/12/2007 | US20070082942 Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft |
| 04/12/2007 | US20070082941 N-(3-cyano-4-methyl-1H-indol-7-yl)-3-cyanobenzenesulfonamide; useful as antitumor agent with angiogenesis inhibitory action |
| 04/12/2007 | US20070082940 Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| 04/12/2007 | US20070082939 Methods and compositions for the treatment of neuropathies and related disorders |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |
| 04/12/2007 | US20070082937 Anti cancer combinations comprising a cox-2 inhibitor |
| 04/12/2007 | US20070082936 High affinity and selectivity for GABA A alpha 5 receptor binding sites; cognitive enhancer; Alzheimer's disease; 3-(5-methyl-3-phenyl-isoxazole-4-carbonyl)-1H-indole-6-carboxylic acid prop-2-ynylamide |
| 04/12/2007 | US20070082934 Substituted 4-aryloxy and 4-arylsulfanyl-phenyl-2-aminothiazoles as inhibitors of cell proliferation |
| 04/12/2007 | US20070082933 Novel thiazolidin-4-one derivatives |
| 04/12/2007 | US20070082932 Pyrrolidine compounds |
| 04/12/2007 | US20070082931 7-Chloro-3-({5-[N-(morpholin-1-ylcarboxamido)methyl]aminomethyl}-([1,2,4]-thiadiazol-3-yl))-1-(tetrahydropyran-4-yl)methyl-1H-indole, hydrochloride salt; treatment of pain |
| 04/12/2007 | US20070082930 Pharmaceutical composition comprising a p2x7 receptor antagonist and a nonsteroidal anti-inflammatory drug |
| 04/12/2007 | US20070082929 Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties |
| 04/12/2007 | US20070082928 Method for treating anxiety disorders, substance abuse/dependence, binge-eating disorders, insomnia and drug-induced flashbacks |
| 04/12/2007 | US20070082927 Piperidine derivative having nmda receptor antagonistic activity |
| 04/12/2007 | US20070082926 Novel polymorphs of racemic, dextrorotatory, and levorotatory enationers of 1-cyclopropyl-6-fluoro-8-methoxy-7-(4-amino-3,3-dimethylpiperidin-1-yl)-1,4-dihydro-4-oxo- quinoline-3-carboxylic acid hydrochloride and mesylate salts |
| 04/12/2007 | US20070082925 Method for the preparation of montelukast acid and sodium salt thereof in amorphous form |
| 04/12/2007 | US20070082924 Processes for preparing different forms of (s)-(+)- clopidogrel bisulfate |
| 04/12/2007 | US20070082923 Process for the synthesis of compounds for selectin inhibition |
| 04/12/2007 | US20070082922 Huperzine a prodrugs and uses thereof |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082920 NAD+-dependent DNA ligase inhibitors |
| 04/12/2007 | US20070082919 Process for Preparing a Co-Precipitate of a Non-Crystalline Solid Drug Substance |
| 04/12/2007 | US20070082918 Neurologically active compounds and compounds with multiple activities |
| 04/12/2007 | US20070082917 Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders |
| 04/12/2007 | US20070082914 4-(4-Methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating pulmonary fibrosis |
| 04/12/2007 | US20070082913 Substituted heterocyclic compounds with CXCR3 antagonist activity |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082911 Novel use of quinolone antibiotics |
| 04/12/2007 | US20070082910 Specific nad(p)h oxidase inhibitor |
| 04/12/2007 | US20070082909 Acyclic Ikur inhibitors |
| 04/12/2007 | US20070082908 Bicycle pyrazole derivative |
| 04/12/2007 | US20070082907 Peroxisome proliferator activated receptor modulators |
| 04/12/2007 | US20070082906 1-(1-{4-[3-(1,3-oxazol- 2-yl)-6-phenyl-1,2,4- triazin-5- yl]benzyl}piperidin-4- yl)-1,3-dihydro-2H- benzimidazol-2-one; inhibit activity of a serine, threonine protein kinase; hyperproliferative disorders, restenosis, inflammation, autoimmune diseases, allergy, asthma |
| 04/12/2007 | US20070082905 Pharmaceutical compositions comprising n-triazolymethyl-piperazine compounds and methods of using same |
| 04/12/2007 | US20070082904 Cycloalkyl derivatives of 3-hydroxy-4-pyridinones field of the invention |
| 04/12/2007 | US20070082903 Remedy for rheumatoid arthritis |
| 04/12/2007 | US20070082902 cancer, inflammation and arthritis, neurodegenerative diseases such Alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
| 04/12/2007 | US20070082901 Pyrazolopyrimidines as protein kinase inhibitors |
| 04/12/2007 | US20070082900 Methods for inhibiting protein kinases |
| 04/12/2007 | US20070082899 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/12/2007 | US20070082898 5 Amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082896 4-{[3,5-Bis(trifluoromethyl)benzyl]-[5-(4-carboxybutoxy)pyrimidin-2-yl]}amino-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester; cholesteryl ester transfer protein (CETP) inhibitors; increasing HDL cholesterol; lowering LDL cholesterol; arteriosclerosis, hyperlipidemia |
| 04/12/2007 | US20070082895 Novel mycobacterial inhibitors |
| 04/12/2007 | US20070082894 Pyrazine-based tubulin inhibitors |
| 04/12/2007 | US20070082893 Active substance combination |
| 04/12/2007 | US20070082892 Benzotriazepine derivatives and their use as gastrin and cholecystokinin receptor ligands |
| 04/12/2007 | US20070082891 Novel pyrrolo[2,1-C] [1,4] benzodiazepine compounds and processes for the preparation thereof |
| 04/12/2007 | US20070082890 Substituted imidazo-[1,5-a][1,2,4]triazolo[1,5-d][1,4] benzodiazepine derivatives |
| 04/12/2007 | US20070082889 inhibitors of voltage-gated sodium channels; (R)-2-hydroxy-1-(4-(6-(2-hydroxyphenyl)pyridin-2-yl)piperazin-1-yl)-4-methylpentan-1-one; antiinflammation, arthritis, migraine, neuralgia, epilepsy, neurodegenerative and psychiatric disorders , anxiety and depression, myotonia, arrhythmia; cancer |
| 04/12/2007 | US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes |
| 04/12/2007 | US20070082887 e.g. 6-Bromo-7-(naphtalen-1-ylmethyl)-5-oxo-8-cyclopropyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic Acid Methyl Ester; inhibit biofilm/pili formation and adherence of bacteria to a host cell |
| 04/12/2007 | US20070082886 bradycardial agent, myocardial ischaemia, angina pectoris, myocardial infarct and associated rhythm disturbances, supraventricular rhythm disturbances, and heart failure; mixture of acetonitrile and water is preheated, ivabradine hydrochloride is added, cooled at room temperature |
| 04/12/2007 | US20070082885 Delta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it |
| 04/12/2007 | US20070082884 Selective serine/threonine kinase inhibitors |
| 04/12/2007 | US20070082883 HIV protease inhibitors |
| 04/12/2007 | US20070082882 Transplatinum complexes with N2O2 donor sets as cytotoxic and antitumor agents |
| 04/12/2007 | US20070082881 Compounds with modifying activity enhanced under hypoxic conditions |
| 04/12/2007 | US20070082880 Thieno [2,3-B] pyridine-5-carbonitriles as protein kinase inhibitors |
| 04/12/2007 | US20070082879 labeled amino acid compounds; to detect brain and body tumors by PET or SPECT tomography; halogenation of cyclic sulfamidate intermediate; 1-amino-1-carboxycyclobutane/pentane halogen-substitued compounds |
| 04/12/2007 | US20070082878 Cytotoxic depsipeptides |
| 04/12/2007 | US20070082876 Novel C18 modified retrosteroids as progesterone receptor modulator compounds |
| 04/12/2007 | US20070082875 Compounds for preparing immunological adjuvant |
| 04/12/2007 | US20070082874 Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 04/12/2007 | US20070082873 Combinations comprising ampa receptor antagonists for the treatment of schizophrenia |
| 04/12/2007 | US20070082872 Indole-containing compounds with anti-tubulin and vascular targeting activity |
| 04/12/2007 | US20070082871 Antiresorptive mutual salt of raloxifene and bisphosphonic acid |
| 04/12/2007 | US20070082870 Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| 04/12/2007 | US20070082869 Multistep process for the physical depolymerization of heparin and products obtained therefrom |
| 04/12/2007 | US20070082868 Seaweed extract composition for treatment of diabetes and diabetic complications |
| 04/12/2007 | US20070082867 Novel cyclodextrin dimers and derivatives thereof, methods for preparing them and their use, in particular, for the solubilizing pharmacologically active substances |
| 04/12/2007 | US20070082863 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 04/12/2007 | US20070082862 Novel antisense oligonucleotide and anti-hiv agent |
| 04/12/2007 | US20070082859 Formulations of AICA riboside |